Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1999
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999038980A9 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999033522A8 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer
10/21/1999WO1999030738A3 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products
10/21/1999WO1999024607A3 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI)
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2800231A1 Porcine adenovirus type 3 genome
10/21/1999CA2718812A1 Porcine adenovirus type 3 genome
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328725A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999CA2328461A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999CA2328157A1 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
10/21/1999CA2326717A1 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2324992A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999CA2324981A1 Peptides
10/21/1999CA2324870A1 Modified biological material
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950189A1 Brca1 associated protein (bap-1) and uses therefor
10/20/1999EP0950107A1 Novel nucleic acid molecules from maize and their use for the production of modified starch
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950068A2 Collagen binding protein compositions and methods of use
10/20/1999EP0950067A1 Affinity purification of polypeptide on protein a matrix
10/20/1999EP0950062A1 Protein markers for esophageal cancer
10/20/1999EP0769065A4 Methods for identifying inhibitors of integrin activation
10/20/1999EP0628057B1 Use of a therapeutical COMPOSITION FOR THE TREATMENT OF THERMAL INJURY
10/20/1999CN1232505A Nucleic acid sequences that encode cell growth regulatory protein and uses thereof
10/20/1999CN1232503A Tumor necrosis factor related ligand
10/20/1999CN1232502A Antibodies against avirulence/pathogenicity proteins of plant pathogens
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232500A Neuritin, a neurogene
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232468A Acquired resistance NPR genes and uses thereof
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232402A Method and compositions for immunomodulation
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999CN1232039A Genetic engineering double specific antibody and its use
10/19/1999US5969126 GNRH-leukotoxin chimeras
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5969109 Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
10/19/1999US5969108 Methods for producing members of specific binding pairs
10/19/1999US5969107 Monoclonal antibody containing antigen recognition sites which mimic antigenic regions of receptors; diagnostic and therapeutic tool for treatment of tumors
10/19/1999US5969102 Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
10/19/1999US5969094 Anti-paramyxovirus screening method and vaccine
10/19/1999US5969093 Secreted proteins
10/19/1999US5968824 Administering agent which modulates biochemical pathway in which products of opioid peptide precursor genes participate; antitumor agents; prevention of opacity of intraocular lens after cataract surgery
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968821 Adenovirus vector containing nucleotide sequence coding polypeptide which binds and inhibits cyclin kinase; screening for agonist or antagonist to cell propagation; develop immunogen; antitumor agents; diagnostic model for disease
10/19/1999US5968818 Nucleic acid coding an enzyme whose presence can be used to acess sensitivity to atherosclerosis
10/19/1999US5968816 Dna molecule which codes for protein involved in cytokine-induced programmed cell death; diagnostic and therapeutic aid in treatment and detection of alzheimer's, parkinson's, psoriasis and cancer
10/19/1999US5968797 Diagnostic and therapeutic tool in treatment of alzheimers disease, atrophying skeletal muscle, swine fever virus and apoptosis; anticarcinogenic/antitumor agents
10/19/1999US5968780 Dendritic cell-derived growth factor
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968768 CD6 ligand encoding sequence
10/19/1999US5968764 Detecting modulators of glucose transport protein; therapy for diabetes and disorders of insulin resistance, by incubating glucose transport protein with test compound, adding transport protein substrate, monitoring effect
10/19/1999US5968763 Method for screening inhibitors of the enzyme which cleaves the anchor of surface proteins from gram positive bacteria
10/19/1999US5968761 Ubiquitin conjugating enzymes
10/19/1999US5968756 Antibody which inhibits activity of tissue type muscle subunit of creatine phosphokinase but not the activity of serum type muscle subunit; for immunoinhibition diagnosis of myocardial infarction
10/19/1999US5968754 Detecting the presence of breast cancer proteins in humans; screening for breast cancer by measuring diagnostic marker for breast cancer in sample
10/19/1999US5968753 Peptides which displace a monoclonal antibody bound to a cell surface antigen on a target cell; for separating specific cells like cd34 positive hematopoeitic stem cells from a heterogeneous cell population
10/19/1999US5968752 Method for identifying an OP-1 analog which binds an ALK-1 receptor
10/19/1999US5968751 Immunoassay to detect antigen using antibodies against binding domain sequence of a serine protease
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999US5968522 Dna and antibiodies directed against polypeptides
10/19/1999US5968514 Polypeptides and proteins for immunology
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968511 ErbB3 antibodies
10/19/1999US5968510 CTLA4 receptor and uses thereof
10/19/1999US5968509 Antibodies with binding affinity for the CD3 antigen
10/19/1999US5968508 Neutralization of pc-1 glycoprotein; treating diabetes
10/19/1999CA2119974C Human cell adhesion molecule and nucleic acid sequences
10/19/1999CA1340790C Method of diagnosis and severity-assessment of human pancreatic disease
10/17/1999CA2268457A1 Mammalian rad1 genes, polypeptides and methods of use
10/16/1999CA2269192A1 Novel g protein coupled receptor
10/14/1999WO1999051986A1 Methods and reagents for targeting organic compounds to selected cellular locations
10/14/1999WO1999051781A1 Hepatitis c virus ns5b compositions and methods of use thereof
10/14/1999WO1999051745A2 Dna immunization against chlamydia infection
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051743A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins